Publicaciones en colaboración con investigadores/as de Universidad de Salamanca (20)

2024

  1. Risk versus Benefit of Tyrosine Kinase Inhibitors for Hepatocellular Carcinoma: A Systematic Review and Meta-Analysis of Randomized Controlled Trials

    Clinical Pharmacology and Therapeutics, Vol. 116, Núm. 2, pp. 328-345

  2. Strategies to enhance the response of liver cancer to pharmacological treatments

    American journal of physiology. Cell physiology, Vol. 327, Núm. 1, pp. C11-C33

2023

  1. Impact of Aberrant β-Catenin Pathway on Cholangiocarcinoma Heterogeneity

    Cells, Vol. 12, Núm. 8

2022

  1. Expression of Chemoresistance-Associated ABC Proteins in Hepatobiliary, Pancreatic and Gastrointestinal Cancers

    Cancers, Vol. 14, Núm. 14

  2. Neuropilin-1 as a Potential Biomarker of Prognosis and Invasive-Related Parameters in Liver and Colorectal Cancer: A Systematic Review and Meta-Analysis of Human Studies

    Cancers, Vol. 14, Núm. 14

2021

  1. Association of foxo3 expression with tumor pathogenesis, prognosis and clinicopathological features in hepatocellular carcinoma: A systematic review with meta-analysis

    Cancers, Vol. 13, Núm. 21

  2. Guidelines for the use and interpretation of assays for monitoring autophagy (4th edition)1

    Autophagy, Vol. 17, Núm. 1, pp. 1-382

  3. Impact of aging on primary liver cancer: epidemiology, pathogenesis and therapeutics

    Aging, Vol. 13, Núm. 19, pp. 23416-23434

2013

  1. Novel artemisinin derivatives with potential usefulness against liver/colon cancer and viral hepatitis

    Bioorganic and Medicinal Chemistry, Vol. 21, Núm. 14, pp. 4432-4441

2007

  1. Effect of cantharidin, cephalotaxine and homoharringtonine on "in vitro" models of hepatitis B virus (HBV) and bovine viral diarrhoea virus (BVDV) replication

    Planta Medica, Vol. 73, Núm. 6, pp. 552-558

  2. The anti-inflammatory flavones quercetin and kaempferol cause inhibition of inducible nitric oxide synthase, cyclooxygenase-2 and reactive C-protein, and down-regulation of the nuclear factor kappaB pathway in Chang Liver cells

    European Journal of Pharmacology, Vol. 557, Núm. 2-3, pp. 221-229

2006

  1. Antiviral effect of artemisinin from Artemisia annua against a model member of the Flaviviridae family, the bovine viral diarrhoea virus (BVDV)

    Planta Medica, Vol. 72, Núm. 13, pp. 1169-1174

2004

  1. Effects of S-adenosylmethionine on intrabiliary glutathione degradation induced by long-term administration of cyclosporin A in the rat

    Toxicology, Vol. 200, Núm. 1, pp. 21-27

  2. S-Adenosylmethionine protects against intrabiliary glutathione degradation induced by long-term administration of cyclosporin A in the rat

    Toxicology, Vol. 201, Núm. 1-3, pp. 239-245

  3. Sequential changes in redox status and nitric oxide synthases expression in the liver after bile duct ligation

    Life Sciences, Vol. 75, Núm. 6, pp. 717-732

2003

  1. Diagnostic imaging in sheep hepatic fascioliasis: Ultrasound, computer tomography and magnetic resonance findings

    Parasitology Research, Vol. 90, Núm. 5, pp. 359-364

  2. Effects of aging and cyclosporin treatment on the hepatobiliary efflux of glutathione

    Life Sciences, Vol. 73, Núm. 26, pp. 3387-3397

  3. TNP-470 inhibits oxidative stress, nitric oxide production and nuclear factor Kappa B activation in a rat model of hepatocellular carcinoma

    Free Radical Research, Vol. 37, Núm. 8, pp. 841-848

2002

  1. Choleresis and inhibition of biliary lipid secretion induced by piperacillin in the rat

    Clinical and Experimental Pharmacology and Physiology, Vol. 29, Núm. 10, pp. 880-884

2000

  1. Enhancement of bile acid pool size, synthesis and secretion by epomediol in the rat

    Digestive Diseases and Sciences, Vol. 45, Núm. 7, pp. 1431-1438